Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Myom3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MYOM3 mRNA | CTD | PMID:22206623 | Myom3 | Rat | 17beta-estradiol | multiple interactions | ISO | MYOM3 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MYOM3 mRNA | CTD | PMID:30165855 | Myom3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYOM3 mRNA | CTD | PMID:32109520 | Myom3 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MYOM3 mRNA | CTD | PMID:32109520 | Myom3 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | bisphenol S results in increased expression of MYOM3 mRNA | CTD | PMID:39298647 | Myom3 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Myom3 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of MYOM3 exon | CTD | PMID:33297965 | Myom3 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of MYOM3 mRNA | CTD | PMID:28959563 | Myom3 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Myom3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Myom3 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MYOM3 mRNA | CTD | PMID:35163327 | Myom3 | Rat | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of MYOM3 mRNA | CTD | PMID:35163327 | Myom3 | Rat | aristolochic acid A | increases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MYOM3 mRNA | CTD | PMID:33212167 | Myom3 | Rat | arsane | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of MYOM3 mRNA | CTD | PMID:36720308 | Myom3 | Rat | arsenic atom | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of MYOM3 mRNA | CTD | PMID:36720308 | Myom3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of MYOM3 gene | CTD | PMID:28931070|PMID:35440735 | Myom3 | Rat | benzo[a]pyrene | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MYOM3 mRNA | CTD | PMID:32417428 | Myom3 | Rat | benzo[a]pyrene | affects methylation | ISO | MYOM3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MYOM3 exon; Benzo(a)pyrene affects the methylation of MYOM3 intron; Benzo(a)pyrene more ... | CTD | PMID:27901495|PMID:30157460 | Myom3 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of MYOM3 mRNA | CTD | PMID:26496021 | Myom3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MYOM3 mRNA | CTD | PMID:36779543 | Myom3 | Rat | bisphenol A | decreases methylation | ISO | MYOM3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MYOM3 gene | CTD | PMID:31601247 | Myom3 | Rat | bisphenol F | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | bisphenol F results in increased expression of MYOM3 mRNA | CTD | PMID:30951980 | Myom3 | Rat | butanal | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of MYOM3 mRNA | CTD | PMID:26079696 | Myom3 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Myom3 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of MYOM3 intron; butylbenzyl phthalate results in increased methylation more ... | CTD | PMID:28392331 | Myom3 | Rat | carbon nanotube | affects expression | ISO | Myom3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog affects the expression of MYOM3 mRNA | CTD | PMID:25554681 | Myom3 | Rat | carbon nanotube | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of MYOM3 mRNA | CTD | PMID:25554681 | Myom3 | Rat | carbon nanotube | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of MYOM3 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25620056 | Myom3 | Rat | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of MYOM3 mRNA | CTD | PMID:18500788 | Myom3 | Rat | CGP 52608 | multiple interactions | ISO | MYOM3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MYOM3 gene] | CTD | PMID:28238834 | Myom3 | Rat | chlorpyrifos | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of MYOM3 mRNA | CTD | PMID:37019170 | Myom3 | Rat | chrysene | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | chrysene results in increased expression of MYOM3 mRNA | CTD | PMID:26377693 | Myom3 | Rat | D-glucose | multiple interactions | ISO | Myom3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Myom3 | Rat | dichloroacetic acid | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of MYOM3 mRNA | CTD | PMID:28962523 | Myom3 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression more ... | CTD | PMID:33729688 | Myom3 | Rat | diquat | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Diquat results in decreased expression of MYOM3 mRNA | CTD | PMID:36851058 | Myom3 | Rat | doxorubicin | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MYOM3 mRNA | CTD | PMID:29803840 | Myom3 | Rat | ethanol | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Ethanol results in increased expression of MYOM3 mRNA | CTD | PMID:30319688 | Myom3 | Rat | folic acid | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of MYOM3 mRNA | CTD | PMID:21867686 | Myom3 | Rat | fructose | multiple interactions | ISO | Myom3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Myom3 | Rat | glucose | multiple interactions | ISO | Myom3 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] more ... | CTD | PMID:37567420 | Myom3 | Rat | graphene oxide | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | graphene oxide results in increased expression of MYOM3 mRNA | CTD | PMID:33227293 | Myom3 | Rat | leflunomide | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of MYOM3 mRNA | CTD | PMID:28988120 | Myom3 | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of MYOM3 mRNA | CTD | PMID:22401849 | Myom3 | Rat | niclosamide | increases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of MYOM3 mRNA | CTD | PMID:36318118 | Myom3 | Rat | okadaic acid | increases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of MYOM3 mRNA | CTD | PMID:38832940 | Myom3 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MYOM3 mRNA | CTD | PMID:35163327 | Myom3 | Rat | pioglitazone | multiple interactions | ISO | Myom3 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOM3 mRNA | CTD | PMID:27935865 | Myom3 | Rat | pirinixic acid | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of MYOM3 mRNA | CTD | PMID:23811191 | Myom3 | Rat | propanal | increases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of MYOM3 mRNA | CTD | PMID:26079696 | Myom3 | Rat | propiconazole | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | propiconazole results in increased expression of MYOM3 mRNA | CTD | PMID:21278054 | Myom3 | Rat | rotenone | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of MYOM3 mRNA | CTD | PMID:29955902 | Myom3 | Rat | silicon dioxide | increases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of MYOM3 mRNA | CTD | PMID:23806026 | Myom3 | Rat | silver atom | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Silver results in increased expression of MYOM3 mRNA | CTD | PMID:27131904 | Myom3 | Rat | silver(0) | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Silver results in increased expression of MYOM3 mRNA | CTD | PMID:27131904 | Myom3 | Rat | sunitinib | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of MYOM3 mRNA | CTD | PMID:31533062 | Myom3 | Rat | tamoxifen | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of MYOM3 mRNA | CTD | PMID:25123088 | Myom3 | Rat | temozolomide | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of MYOM3 mRNA | CTD | PMID:31758290 | Myom3 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of MYOM3 mRNA | CTD | PMID:26496021 | Myom3 | Rat | tetrachloroethene | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of MYOM3 mRNA | CTD | PMID:28973375 | Myom3 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MYOM3 mRNA | CTD | PMID:33387578 | Myom3 | Rat | tetraphene | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of MYOM3 mRNA | CTD | PMID:26377693 | Myom3 | Rat | trichloroethene | decreases expression | ISO | Myom3 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of MYOM3 mRNA | CTD | PMID:28973375 | Myom3 | Rat | triptonide | increases expression | ISO | Myom3 (Mus musculus) | 6480464 | triptonide results in increased expression of MYOM3 mRNA | CTD | PMID:33045310 | Myom3 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | MYOM3 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of MYOM3 mRNA | CTD | PMID:29024780 | Myom3 | Rat | urethane | decreases expression | ISO | MYOM3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of MYOM3 mRNA | CTD | PMID:28818685 | Myom3 | Rat | valproic acid | increases methylation | ISO | MYOM3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MYOM3 gene | CTD | PMID:29154799 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















